LONDON, July 4, 2016 /PRNewswire/ -- This BCC Research report provides an in-depth study of the global biopsy devices methods by device, therapautic segments and geographic markets from 2012 through 2018, with five-year CAGR projections from 2015 through 2020. It focuses on key imaging technologies used in the process of performing biopsies such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and others.
Use this report to:
Assess the dynamics that significantly impact the growth of the biopsy device market.
Estimate the biopsy device market and its subsegments from 2014 through 2020 by procedures and by geographical locations.
Provide segmented analysis based on devices, therapeutic segments and geographical locations.
Thoroughly evaluate market trends and technology assessments.
Highlights
The global market for biopsy devices should reach around roughly $2.1 billion by 2020 from over $1.5 billion in 2015, a compound annual growth rate (CAGR) of 6.2% from 2015 to 2020.
The North American market should reach $868.8 million by 2020 from $663.9 million in 2015, at a CAGR of 5.5% from 2015 to 2020.
The European market should reach $785.3 million by 2020 from $586.0 million in 2015, at a CAGR of 6.0% from 2015 to 2020.
STUDY OBJECTIVES
The objectives of this report are to:
Assess the dynamics that have significant impact on the growth of the biopsy device market.
Estimate the biopsy device market and its subsegments from 2014 through 2019 by procedures and by geographical locations.
Analyze the key strategies, competitive insights and development of key companies in the market.
Provide segmented analysis based on devices, therapeutic segments and geographical locations.
Thoroughly analyze the market trends and technology assessments.
Study intensively the challenges that must be addressed and opportunities that can be leveraged by market participants.
STUDY BACKGROUND
The key criterion for successful cancer treatment is early diagnosis of the disease.
However, in the past it was extremely difficult for doctors to recommend a biopsy to patients that were considered low risk (even though "low risk" did not mean a patient did not need a biopsy for confirmation) because conventional biopsy methods involved complex technical issues along with increased trauma and stress among the patients.
However, with the increased adoption of noninvasive methods, the process is now being recommended for low-risk patients as well. Moreover, it became clear that the knowledge based on a biopsy also reduces the stress level and recovery period of the patient. Novel approaches to improve cancer diagnosis, including biopsy methods, are being introduced, which in turn are increasing the number of biopsy procedures being performed. Increased awareness and acceptance among patients are also driving the growth in the number of biopsies performed.
Key innovations are discussed in the report and market estimates are given for both conventional and advanced biopsy procedures. The report also profiles key market players that are focused on innovative biopsy procedures.
SCOPE OF THE REPORT
This research report presents an in-depth analysis of the global market for biopsy devices by device type, therapeutic segments and geographic markets. It discusses key devices such as breast biopsy devices, core needle biopsy (CNB) devices, fine needles, gastrointestinal (GI) biopsy devices, robotic guidance systems technologies involved in thermal ablation techniques and nonthermal ablation techniques.
The market by type of procedure is also discussed, which includes trends and market estimates of key therapeutic areas such as breast cancer, gastrointestinal cancer, lung cancer and cervical cancer, among others. The report focuses on key imaging technologies used in the process of performing biopsies such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and others. The report also reviews the supply chain from manufacturers to surgeons.
The report excludes drugs used during a biopsy and any device that is used in the cancer treatment process.
Download the full report: https://www.reportbuyer.com/product/2212013/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article